Published in Eur Heart J on July 01, 2001
Adenosine receptors in wound healing, fibrosis and angiogenesis. Handb Exp Pharmacol (2009) 0.94
Effects of exercise training on coronary collateralization and control of collateral resistance. J Appl Physiol (1985) (2011) 0.89
The collateral circulation of the heart. BMC Med (2013) 0.83
Coronary angiogenesis: dipyridamole is back on the stage? Eur Heart J (2001) 0.77
Potential of delayed gadolinium enhancement magnetic resonance imaging for quantification of reverse remodeling of the peri-infarct zone in patients with ischemic cardiomyopathy treated with chronic vasodilator therapy: initial experience. J Thorac Imaging (2012) 0.75
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart (2006) 2.33
Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation (1983) 2.05
Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol (1997) 1.88
Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol (1983) 1.86
Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol (1996) 1.67
Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries. Circ Res (1979) 1.65
A2A-adenosine receptor reserve for coronary vasodilation. Circulation (1998) 1.55
Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J (1995) 1.49
Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol (1985) 1.45
Theophylline for the treatment of atrioventricular block after myocardial infarction. Ann Intern Med (1995) 1.45
Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation (1986) 1.41
The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther (1998) 1.40
Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation (1991) 1.38
Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res (1983) 1.37
Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J Am Soc Nephrol (1999) 1.28
Atrioventricular conduction disturbances during hypoxia. Possible role of adenosine in rabbit and guinea pig heart. Circ Res (1980) 1.23
Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res (1999) 1.23
Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. Invest Ophthalmol Vis Sci (2001) 1.20
Ionic basis for the antagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res (1984) 1.18
Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ Res (1982) 1.15
Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther (2001) 1.12
Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J Leukoc Biol (1999) 1.10
Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels. J Pharmacol Exp Ther (1999) 1.09
Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells. Mol Pharmacol (1998) 1.06
Adenosine-sensitive afterdepolarizations and triggered activity in guinea pig ventricular myocytes. Circ Res (1992) 1.05
Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovasc Res (1994) 1.05
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor. Bioorg Med Chem Lett (2000) 1.04
Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node. Pflugers Arch (1985) 1.03
Paroxysmal supraventricular tachycardia with Wenckebach block: evidence for reentry within the upper portion of the atrioventricular node. J Am Coll Cardiol (1984) 1.03
Effect of adenosine and adenosine-5'-triphosphate on atrioventricular conduction in patients. J Am Coll Cardiol (1985) 1.01
Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2). Biochem Pharmacol (2001) 1.00
Dromotropic effects of adenosine and adenosine antagonists in the treatment of cardiac arrhythmias involving the atrioventricular node. Circulation (1984) 1.00
Robust anti-arrhythmic efficacy of verapamil and flunarizine against dofetilide-induced TdP arrhythmias is based upon a shared and a different mode of action. Br J Pharmacol (2010) 0.99
Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium. Br J Pharmacol (2007) 0.98
Cardiac glycoside stimulation of inward Ca++ current in vascular smooth muscle of canine coronary artery. J Pharmacol Exp Ther (1979) 0.97
Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node. Am J Physiol (1992) 0.97
Cellular basis for the negative dromotropic effect of adenosine on rabbit single atrioventricular nodal cells. Circ Res (1996) 0.96
2-substituted pi system derivatives of adenosine that are coronary vasodilators acting via the A2A adenosine receptor. Nucleosides Nucleotides Nucleic Acids (2001) 0.96
Canine myocardial adenosine and lactate production, oxygen consumption, and coronary blood flow during stellate ganglia stimulation. Circ Res (1979) 0.96
Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts. Circulation (1984) 0.95
Electrophysiological and receptor binding studies to assess activation of the cardiac adenosine receptor by adenine nucleotides. Circ Res (1991) 0.95
Myocardial infarction related atrial fibrillation: role of endogenous adenosine. Heart (1997) 0.95
Evidence for adenosine mediation of atrioventricular block in the ischemic canine myocardium. J Clin Invest (1981) 0.95
Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes. Circ Res (1996) 0.94
Sinus slowing and pacemaker shift caused by adenosine in rabbit SA node. Pflugers Arch (1985) 0.93
Species-dependent effects of adenosine on heart rate and atrioventricular nodal conduction. Mechanism and physiological implications. Circ Res (1990) 0.93
Adenosine release during early and sustained exercise of canine skeletal muscle. Am J Physiol (1980) 0.91
Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation (1999) 0.91
Extraction of adenine nucleotides from cultured endothelial cells. Anal Biochem (1986) 0.90
Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects. Circulation (2000) 0.90
A partial agonist of the A(1)-adenosine receptor selectively slows AV conduction in guinea pig hearts. Am J Physiol Heart Circ Physiol (2001) 0.89
Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart. Br J Pharmacol (2000) 0.89
Electrophysiological and functional effects of adenosine on ventricular myocytes of various mammalian species. Am J Physiol (1996) 0.89
Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors. J Med Chem (1994) 0.87
Induction of atrioventricular node reentrant tachycardia with adenosine: differential effect of adenosine on fast and slow atrioventricular node pathways. J Am Coll Cardiol (1997) 0.87
Antiadrenergic effects of adenosine on His-Purkinje automaticity. Evidence for accentuated antagonism. J Clin Invest (1988) 0.87
Differential A1 adenosine receptor reserve for two actions of adenosine on guinea pig atrial myocytes. Mol Pharmacol (1997) 0.87
Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine. J Med Chem (1997) 0.87
A novel irreversible antagonist of the A1-adenosine receptor. Mol Pharmacol (1996) 0.87
Adenosine receptor antagonists and retinal neovascularization in vivo. Invest Ophthalmol Vis Sci (2001) 0.87
Agonist-independent effect of an allosteric enhancer of the A1 adenosine receptor in CHO cells stably expressing the recombinant human A1 receptor. J Pharmacol Exp Ther (1997) 0.86
Modulation of atrioventricular nodal function by metabolic and allosteric regulators of endogenous adenosine in guinea pig heart. Circulation (1996) 0.86
Validation of Furchgott's method to determine agonist-dependent A1-adenosine receptor reserve in guinea-pig atrium. Br J Pharmacol (1998) 0.86
Electrophysiologic effects of dipyridamole on atrioventricular nodal conduction and supraventricular tachycardia. Role of endogenous adenosine. Circulation (1989) 0.85
Mechanism of the negative inotropic effect of adenosine in guinea pig atrial myocytes. Am J Physiol (1994) 0.85
Plasma adenosine and hypoxemia in patients with sleep apnea. J Appl Physiol (1985) (1988) 0.85
Blockade of Ca2+ dependent rat atrial slow action potentials by adenosine and lanthanum. Pflugers Arch (1979) 0.85
Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node. Circ Res (1986) 0.85
Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors. Cell Mol Life Sci (2005) 0.84
Reduction in preretinal neovascularization by ribozymes that cleave the A2B adenosine receptor mRNA. Circ Res (2003) 0.84
Effect of adenosine on atrioventricular conduction. II: Modulation of atrioventricular node transmission by adenosine in hypoxic isolated guinea pig hearts. Circ Res (1986) 0.84
Adenosine-induced changes in atrial action potential: contribution of Ca and K currents. Am J Physiol (1990) 0.84
Enhanced sensitivity of heart cells to adenosine and up-regulation of receptor number after treatment of guinea pigs with theophylline. Circ Res (1989) 0.84
Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects. Cardiovasc Res (1993) 0.84
Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine. Circ Res (1994) 0.84
Antiadrenergic action of adenosine on ventricular myocardium in embryonic chick hearts. J Mol Cell Cardiol (1982) 0.84
Interstitial adenosine in guinea pig hearts: an index obtained by epicardial disks. Am J Physiol (1990) 0.84
Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans. Circulation (1996) 0.83
Antagonism of the effects of adenosine and hypoxia on atrioventricular conduction time by two novel alkylxanthines: correlation with binding to adenosine A1 receptors. J Pharmacol Exp Ther (1987) 0.83
Downregulation and desensitization of A1-adenosine receptors in embryonic chicken heart. Am J Physiol (1989) 0.83
Potentiating effect of acetylcholine on stimulation by isoproterenol of L-type Ca2+ current and arrhythmogenic triggered activity in guinea pig ventricular myocytes. J Cardiovasc Electrophysiol (1998) 0.82
Differential A(1)-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cells. Br J Pharmacol (2000) 0.82
Selective potentiation by an A1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart. J Pharmacol Exp Ther (1993) 0.82
ATP promotes development of afterdepolarizations and triggered activity in cardiac myocytes. Am J Physiol (1994) 0.82
An unusual receptor mediates adenosine-induced SA nodal bradycardia in dogs. Am J Physiol (1989) 0.81
Role of adenosine on ventricular overdrive suppression in isolated guinea pig hearts and Purkinje fibers. Circ Res (1985) 0.81
[Substernal goiter: new diagnostic methods and treatment]. Minerva Chir (1993) 0.81
Differential antagonism of cardiac actions of adenosine by theophylline. Cardiovasc Res (1996) 0.81
Effects of hypoxia and ischaemia on coronary vascular resistance, A-V node conduction and S-A node excitation. Acta Med Scand Suppl (1985) 0.81
Role of adenosine as mediator of bradyarrhythmias during hypoxia in isolated guinea pig hearts. Cardiovasc Res (1986) 0.80
Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: possible role of adenosine. J Am Coll Cardiol (1986) 0.80
Basis for the selective reduction of pulmonary vascular resistance in humans during infusion of adenosine. J Appl Physiol (1985) (1994) 0.80